With R&D pipelines arguably at their healthiest state ever, there are unprecedented opportunities for Pharma innovators to bring new products to market. At the same time, profit pressures combined with increasing clinical development and marketing costs are causing internal resource constraints on both the R&D and commercial fronts. Therefore, novel approaches to resourcing are needed.
As many of you are starting next year’s planning process and will be addressing resourcing issues, you’ll want to join this webinar on a new approach to resource allocation. KPMG LLP’s Strategy leaders Bill Shew and Peter Gilmore, as well as Peter Ray, VP, Strategic & Operational Portfolio Management, at Bristol-Myers Squibb, will discuss how to implement a cutting-edge approach.
During the webcast you will learn how to enhance resource allocation by, for example:
Integrating commercial input into R&D planning early on
Adjusting resourcing plans to reflect changing market dynamics
Streamlining pipeline investments
Balancing commercial resourcing needs globally and locally